Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Genesis Lifestyle Medicine vs Roboclinic

Genesis Lifestyle Medicine
Graded #392

Lower grade

vs+7.299999999999997
Roboclinic
Graded #233

Higher grade

The verdict

Roboclinic takes it — 65/100 to 57.7/100.

Roboclinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Roboclinic is an AI-first telehealth platform, operated by BrickFi, Inc., that starts you with an AI health assistant and then routes you to a board-certified provider for GLP-1 weight-loss care.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRoboclinic +5
45
50
Dose & formulationRoboclinic +22
53
75
Clinical oversightRoboclinic +6
78
84
Labs & monitoringRoboclinic +1
52
53
FulfillmentRoboclinic +8
67
75
Contract termsGenesis Lifestyle Medicine +8
55
47
Genesis Lifestyle Medicine · left barRoboclinic · right bar

The numbers

MetricGenesis Lifestyle MedicineRoboclinic
WeighScore57.7/10065/100
GradeCC
Scorecard rank#392#233
SemaglutideNot disclosed$179/mo (12-month plan, compounded)
TirzepatideNot disclosed$299/mo (12-month plan, compounded)
Coverage8 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes

Strengths

  • 18 physical clinics allow in-person consults and injections across 8 states
  • Dual modality — compounded sema/tirz plus brand-name Wegovy and Zepbound on one platform
  • Med spa model lets patients combine weight loss, hormone therapy, and aesthetics
  • Established brand with an 18-location footprint and patient testimonials
  • Telehealth available for remote patients in served states

Where it loses points

  • Pricing not disclosed publicly — gated behind the consultation flow
  • Specific 503A/503B pharmacy partner not named, and the designation not specified
  • No FDA compounded-medication disclaimer visible on the homepage
  • Named medical director not formally disclosed (only a 'Dr. Spinoso' testimonial)
  • Corporate legal entity and governing law not disclosed
Roboclinic

Graded #233 · C

Strengths

  • Compounded semaglutide from $179/mo and tirzepatide from $299/mo on 12-month plans
  • One all-in price bundles the provider consult, prescription, and delivery
  • Offers both injectable and oral (tablet) compounded semaglutide
  • 'Same price, every dose' means your cost does not rise as the dose increases
  • AI-first intake with board-certified provider review; no insurance necessary

Where it loses points

  • Lowest rates require a 12-month plan; month-to-month runs $299/mo (semaglutide) to $399/mo (tirzepatide)
  • Individual compounding pharmacies are not named; fulfillment is routed through OpenLoop Health
  • No published per-state list; site claims 'all 50 states, restrictions apply' and gates doctor review by region
  • Refunds limited to your most recent billing cycle; none for used or partially used periods
  • Operated by BrickFi, Inc., a newer brand with limited independent track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard